Insider trading · Q3 2026 · CIK 1831097

agilon health, inc. (AGL) insider trading.

In Q3 2026, insiders at agilon health, inc. reported 3 non-derivative transactions on 3 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.

Transactions
3
Purchases (P)
0
Sales (S)
0
Net shares, P minus S
0
Insiders
3
Last filed
2026-08-18

Insiders

InsiderRelationshipTransactionsBuysSales
Gertsch TimothyOfficer · Chief Accounting Officer100
Zamore DeniseOfficer · Chief Legal Officer100
Schwaneke Jeffrey A.Officer · Chief Financial Officer100

Transactions

3 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-08-16Gertsch TimothyF (D)17$96.914,152Form 4
2026-08-01Zamore DeniseF (D)37$91.6166,075Form 4
2026-07-01Schwaneke Jeffrey A.F (D)2,311$111.74138,031Form 4

Transaction codes in this quarter

Get AGL insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1831097&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · AGL company page · agilon health, inc. on SEC.gov

Questions

Are insiders buying or selling agilon health, inc. (AGL)?

In Q3 2026, insiders at agilon health, inc. reported 3 non-derivative transactions on 3 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these agilon health, inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/agl.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.